21 May 2013
Keywords: pfizer, antifungal, vfend, cleared, usa, serious, infections
Article | 03 June 2002
Pfizer gained approval for a new product in its antifungal franchiseVfend (voriconazole) in the USA on May 28, and said the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 June 2002
20 May 2013
© 2013 thepharmaletter.com